19th WCIRDC Hybrid CME Conference 2021

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 19th year, is a unique and exciting multidisciplinary CME program. The Congress is the premier global meeting dedicated to diabetes, obesity, lipids, cardiovascular-kidney and liver disease linking basic research to clinical practice in pursuit of our theme: Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.
 
WCIRDC 2021 will be held at the Universal City Hotel in Los Angeles on December 2-4, and will present a Hybrid Meeting - a combination of Live-in person event with a component of Live Streaming Webinar followed by 90 days on demand.

 This is a CME meeting where participants can earn up 30 CME & ABIM-MOC credits.
 
For nearly two decades, WCIRDC has brought researchers, physicians, clinicians, and other healthcare professionals together for a distinctive international program that bridges the latest developments from bench-to-bedside. “I heard it first at the Congress” is a frequent remark from the audience. WCIRDC offers attendees a unique experience to interact with the distinguished global faculty for a collaborative experience that explores the newest understanding of metabolic diseases and the development of future therapeutic modalities.

Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR), diabetes, obesity, and CVD, the Congress’ focus has expanded to cover the kidney, liver, brain, bone, cancer, and more.  The congress addresses dyslipidemia, atherosclerosis, hypertension,  hypercoagulation, inflammation, and energy metabolism. It provides the newest clinical updates on pharmaceutical interventions such as incretins, SGLT2i’s, PCSK9i’s, and EPA omega 3 to name a few, assessing their impact on practice. The goal is to understand the state-of-the-art pathophysiology, new medical interventions, and to develop appropriate comprehensive clinical management strategies.

To make basic and clinical research topics relevant to clinical medicine, following each session there will be live Q&A and a discussion on clinical implications to practice. To promote more interaction with faculty and provide further insights, each day will end with one hour of live panel, with a summary of the day’s sessions, commentary, and Q&A.

The Congress attracts state-of-the-art abstracts by young, up-and-coming researchers as well as recognized leaders from around the globe. The abstracts will be available for 90 days on the conference website and published in Metabolism, a peer-reviewed journal, with over 40,000 unique monthly viewers worldwide, which is in the top 10% of endocrinology, diabetes, and metabolism journals.

Proceedings from the congress are featured in global medical news venues such as Healio, Medscape, Endocrinology & Cardiology Today, Clinical Endocrinology News and more, while articles are being published in peer-reviewed journals like Journal of Diabetes, Endocrine Practice, Metabolism, Diabetes & Vascular Disease Research, and others.